![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1402585
´ÙºóÄ¡ ½Ã½ºÅÛ ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº° ¹× Áö¿ªº°Da Vinci Systems Market, By Product Type, By Application, By End User, By Region |
´ÙºóÄ¡ ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð´Â 2023³â 17¾ï 6,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2030³â 53¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¹Ãø ±â°£ Áß CAGRÀº 17.1%·Î Àü¸ÁµË´Ï´Ù.
º¸°í ¹üÀ§ | º¸°í¼ ¼¼ºÎÁ¤º¸ | ||
---|---|---|---|
±âÁسâ | 2022³â | ½ÃÀå ±Ô¸ð(2023³â) | 17¾ï 6,000¸¸ ´Þ·¯ |
½ÇÀû µ¥ÀÌÅÍ | 2018-2021³â | ¿¹Ãø ±â°£ | 2023-2030³â |
¿¹Ãø ±â°£ÀÇ CAGR | 17.10% | ½ÃÀå ±Ô¸ð ¿¹Ãø(2030³â) | 53¾ï ´Þ·¯ |
´ÙºóÄ¡ ½Ã½ºÅÛÀº ½Å¼¼´ë ·Îº¿ ¼ö¼ú Ç÷§ÆûÀ¸·Î, ¿Ü°úÀǻ簡 º¹ÀâÇÑ Àúħ½À ¼ö¼úÀ» °ÈµÈ Á¦¾î, Á¤¹Ðµµ, ½Ã°¢È ¹× ÀÎü°øÇÐÀ» ¹ÙÅÁÀ¸·Î ¼öÇàÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ·Îº¿ ½Ã½ºÅÛÀº 3D ½Ã°¢È, ¼Õ¸ñ ±â±¸, ¸ð¼Ç ½ºÄÉÀϸµ ¹× ¶³¸² ÇÊÅÍ ±â´ÉÀ» ÅëÇÕÇÏ¿© ȯÀÚÀÇ ¸ö¿¡¼ÀÇ ¿òÁ÷ÀÓÀ» ¿Ü°úÀǰ¡ º¸´Ù °íµµ·Î Á¦¾îÇÒ ¼ö ÀÖµµ·Ï ÇÕ´Ï´Ù. ´ÙºóÄ¡ ½Ã½ºÅÛÀº ³·Àº ħ½ÀÀ¸·Î ¼öÇàÇÒ ¼ö ÀÖ´Â ¼ö¼úÀÇ ¼ö¸¦ ´Ã¸®°í ÅëÁõ ¿ÏÈ, ÀÔ¿ø ±â°£ ´ÜÃà, ȸº¹ ½Ã°£ ´ÜÃà µî ȯÀÚ¿¡°Ô Å« ÀÌÀÍÀ» Á¦°øÇÕ´Ï´Ù.
ÀÌ È¸»çÀÇ ÁÖ·Â Á¦Ç°ÀÎ ´ÙºóÄ¡ ¼ö¼ú ½Ã½ºÅÛÀº ·Îº¿ ÆÈ°ú ¿Ü°úÀǻ簡 ±â±¸¸¦ Á¤È®ÇÏ°Ô Á¶ÀÛÇÒ ¼ö ÀÖ´Â ÄַܼΠ±¸¼ºµÇ¾î ÀÖ½À´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ¼ö¼ú ºÐ¾ßÀÇ 3D °íÈÁú ºä¸¦ Á¦°øÇÏ¿© ¿Ü°ú Àǻ簡 Çâ»óµÈ ½Ã°¢È·Î ÀýÂ÷¸¦ ¼öÇàÇÒ ¼ö ÀÖ½À´Ï´Ù. ·Îº¿ ÆÈÀ» »ç¿ëÇÏ¸é ½Ã½ºÅÛÀÌ ¿Ü°úÀÇ»çÀÇ ¿òÁ÷ÀÓÀ» Á¤È®ÇÑ µ¿ÀÛÀ¸·Î º¯È¯Çϰí, Àΰ£ ¿À·ùÀÇ À§ÇèÀ» ÁÙÀ̰í, ȯÀÚ °á°ú¸¦ °³¼±ÇÕ´Ï´Ù.
¼¼°èÀÇ ´ÙºóÄ¡ ½Ã½ºÅÛ ½ÃÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÇâÈÄ ¼ö³â°£ Å« ¼ºÀåÀÌ ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃËÁø¿äÀÎ Áß Çϳª´Â ³·Àº ħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¼úÀº ±âÁ¸ÀÇ °³º¹ ¼ö¼ú¿¡ ºñÇØ ÀÔ¿ø ±â°£ ´ÜÃà, ¼ö¼ú ÈÄ ÅëÁõ ¿ÏÈ, ȸº¹ ½Ã°£ ´ÜÃà, Àý°³ â Ãà¼Ò µî ¸î °¡Áö ÀåÁ¡ÀÌ ÀÖ½À´Ï´Ù. ´ÙºóÄ¡ ½Ã½ºÅÛÀÇ ·Îº¿ ¼ö¼ú ±â¼úÀº ħ½À ¼ö¼ú¿¡ ÀûÇÕÇÏ¸ç ¿Ü°ú ÀÇ»ç¿Í ȯÀÚµé »çÀÌ¿¡¼ ÀαⰡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.
½ÃÀåÀÇ ¶Ç ´Ù¸¥ ÃËÁø¿äÀÎÀº ¿Ü°úÀû °³ÀÔÀ» ÇÊ¿ä·Î ÇÏ´Â ½ÉÇ÷°ü ÁúȯÀ̳ª ¾Ï µî ¸¸¼ºÁúȯÀÇ À¯º´·üÀÌ »ó½ÂÇϰí ÀÖ´Ù´Â °ÍÀÔ´Ï´Ù. ´ÙºóÄ¡ ½Ã½ºÅÛÀº º¹ÀâÇÑ ÀýÂ÷¿¡¼ ¿Ü°úÀǻ翡°Ô Á¤È®ÇÑ ÅëÁ¦¿Í ½Ã°¢È¸¦ Á¦°øÇÒ ¼ö Àֱ⠶§¹®¿¡ ÀÌ·¯ÇÑ Áúº´ÀÇ Ä¡·á¿¡ ÀÌ»óÀûÀÎ ¼±ÅÃÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, Journal of the American College of Cardiology¿¡ µû¸£¸é 2021³â¿¡´Â 190¸¸ ¸íÀÇ ½ÉÇ÷°ü ÁúȯÀ¸·Î ÀÎÇÑ »ç¸Á°ú Àü ¼¼°è 370¸¸ ¸íÀÇ »ç¸ÁÀÌ º¸°íµÇ¾úÀ¸¸ç, ÀÌ´Â °Ç°ÇÑ Ã¼Áߺ¸´Ù ³ôÀº üÁß°ú °ü·ÃÀÌ ÀÖ½À´Ï´Ù. °Ô´Ù°¡ 2021³â¿¡´Â Àα¸ 100,000¸í´ç ¾à 1,560¸íÀ̾ú½À´Ï´Ù.
±×·¯³ª ´ÙºóÄ¡ ½Ã½ºÅÛÀ̳ª °ü·Ã ÀýÂ÷ÀÇ °í¾× µî ½ÃÀå¿¡´Â ÀÏÁ¤ÇÑ ¾ïÁ¦¿äÀεµ ÀÖ½À´Ï´Ù. ƯÈ÷ ÇコÄÉ¾î ¿¹»êÀÌ Á¦ÇÑµÈ °³¹ßµµ»óÁö¿ª¿¡¼´Â ·Îº¿½Ã½ºÅÛ µµÀÔ¿¡ ÇÊ¿äÇÑ ÃʱâÅõÀÚ ¹× Áö¼ÓÀûÀÎ À¯Áöº¸¼ö ºñ¿ëÀÌ º¸±ÞÀ» Á¦ÇÑÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ·Îº¿ ¼ö¼ú°ú °ü·ÃµÈ »óȯ Á¤Ã¥ ¹× ±ÔÁ¦ ¹®Á¦´Â ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.
ÀÌ·¯ÇÑ °úÁ¦¿¡µµ ºÒ±¸ÇÏ°í ½ÃÀå¿¡´Â ¸î °¡Áö ¼ºÀå ±âȸ°¡ ÀÖ½À´Ï´Ù. È»ó󸮴ɷ Çâ»óÀ̳ª ±â±¸ÀÇ ¼ÒÇüÈ µî ·Îº¿¼ö¼ú ½Ã½ºÅÛÀÇ ±â¼úÀû Áøº¸°¡ ½ÃÀå È®´ëÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °Ô´Ù°¡ ·Îº¿ ¼ö¼ú ±â¼úÀ» Çâ»ó½Ã۱â À§ÇØ ¿Ü°ú Àǻ縦 À§ÇÑ ±³À° ¹× ±³À° ÇÁ·Î±×·¥ÀÌ ÁÖ¸ñÀ» ¹Þ°í ÀÖ´Â °Íµµ ½ÃÀåÀÇ ÀáÀç·ÂÀ» ´õ¿í ³ô¿©ÁÖ°í ÀÖ½À´Ï´Ù.
The Da Vinci systems market size is expected to reach US$ 5.30 billion by 2030, from US$ 1.76 billion in 2023, at a CAGR of 17.1% during the forecast period.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2022 | Market Size in 2023: | US$ 1.76 Bn |
Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
Forecast Period 2023 to 2030 CAGR: | 17.10% | 2030 Value Projection: | US$ 5.30 Bn |
Da Vinci systems are a new generation of robotic surgical platforms that enable surgeons to perform complex minimally invasive procedures with enhanced control, precision, visualization, and ergonomics. These robotic systems integrate 3D visualizations, wristed instruments, motion scaling and tremor filtration capabilities to grant surgeons enhanced control over their movements inside the patient's body. The da Vinci systems have helped increase the number of surgeries that can be done minimally invasively, leading to significant patient benefits such as less pain, shorter hospital stays, and quicker recovery times.
The Da Vinci surgical system, the flagship product of the company, consists of robotic arms and a console that allows surgeons to control the instruments with great precision. The system provides a 3D high-definition view of the surgical field, enabling surgeons to perform procedures with enhanced visualization. With its robotic arms, the system translates the surgeon's movements into precise actions, reducing the risk of human error and improving patient outcomes.
The global Da Vinci systems market is expected to witness significant growth in the coming years, driven by several factors. One of the major drivers is the increasing demand for minimally invasive surgical procedures. These procedures offer several advantages over traditional open surgeries, including shorter hospital stays, reduced post-operative pain, faster recovery time, and smaller incisions. Da Vinci Systems' robotic surgery technology is well-suited for minimally invasive procedures, contributing to its growing popularity among surgeons and patients alike.
Another driver for the market is the rising prevalence of chronic diseases, such as cardiovascular disorders and cancer, which require surgical interventions. The ability of Da Vinci systems to provide surgeons with precise control and visualization during complex procedures makes it an ideal choice for the treatment of such conditions. For instance, according to the Journal of the American College of Cardiology, in 2021, an estimated 1.9 million cardiovascular deaths and 3.7 million deaths globally in total were reported, which were linked to a higher than healthy body weight. Additionally, the overall impact on health, measured as disability-adjusted life years (DALYs), due to excess body weight, was approximately 1,560 per 100,000 people in 2021.
However, the market also faces certain restraints, such as the high cost of Da Vinci systems and the associated procedures. The initial investment required for acquiring the robotic system and the ongoing maintenance costs may limit its adoption, especially in developing regions with limited healthcare budgets. Additionally, reimbursement policies and regulatory challenges related to robotic surgeries may also hinder market growth.
Despite these challenges, the market presents several opportunities for growth. Technological advancements in robotic surgery systems, such as improved imaging capabilities and miniaturized instruments, are expected to drive market expansion. Moreover, the increasing focus on training and education programs for surgeons to enhance their skills in robotic surgery further augments the market potential.
Da Vinci Systems Market Segmentation: